Harvest Portfolios Group’s GSK GSK Stock Holding History

Harvest Portfolios Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.18M	Hold	41,500	–	–	0.03%	170
2026 Q1	$2.29M	Sell	41,500 -5,700	-12%	-$309K	0.04%	175
2025 Q4	$2.31M	Sell	47,200 -3,000	-6%	-$140K	0.04%	152
2025 Q3	$2.17M	Hold	50,200	–	–	0.04%	155
2025 Q2	$1.93M	Hold	50,200	–	–	0.04%	152
2025 Q1	$1.94M	Buy	50,200 +1,100	+2%	+$40.3K	0.06%	129
2024 Q4	$1.66M	Hold	49,100	–	–	0.06%	128
2024 Q3	$2.01M	Buy	+49,100	New	+$2.01M	0.07%	122

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Harvest Portfolios Group's GSK Position: Q2 2026 in Review

Harvest Portfolios Group held its GSK (GSK) position steady in Q2 2026 at 41,500 shares worth $2.18M. The position accounts for 0.03% of the portfolio, ranked #170.

Harvest Portfolios Group first reported a position in GSK in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.31M in Q4 2025. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Harvest Portfolios Group held 41,500 shares of GSK worth $2.18M as of Q2 2026.
Harvest Portfolios Group left its GSK share count unchanged in Q2 2026.
GSK made up 0.03% of Harvest Portfolios Group's portfolio in Q2 2026, its #170 holding.
Harvest Portfolios Group first reported a position in GSK in Q3 2024 and has held it in 8 quarters since.
Harvest Portfolios Group's GSK position peaked at $2.31M in Q4 2025.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Harvest Portfolios Group's 13F filing for Q2 2026, filed 13 Aug 2026.